Key result
Hypertension affects ~19% of adults living with HIV in India.
Why the study?
Hypertension is increasingly recognized among people living with HIV due to improved survival with antiretroviral therapy, and this study aimed to estimate the pooled prevalence of hypertension among adult PLHIV in India.
Meta-Analysis (n=39,809)
Yes
Approximately one in five adults living with HIV in India has hypertension (19.37%), highlighting a notable cardiovascular risk burden in this population, though high heterogeneity limits national generalizability.
Answers are grounded in this paper and cite their sources.
Hypertension affects ~19% of PLHIV in India; leaves open national burden estimates given high heterogeneity and facility-based sampling.
Hypertension is a modifiable risk factor for cardiovascular disease and is increasingly recognized among people living with human immunodeficiency virus (PLHIV) due to improved survival with antiretroviral therapy. This systematic review and meta-analysis aimed to estimate the pooled prevalence of hypertension among adult PLHIV in India. A comprehensive search was conducted in Cochrane CENTRAL, PubMed, Scopus, and Web of Science. Observational studies reporting hypertension prevalence among adult PLHIV in India were included. RStudio was used to estimate pooled prevalence by a random-effects model. Heterogeneity was assessed using the I² statistic, and publication bias was evaluated using the funnel plot, Egger’s test, and Begg’s test. A total of 315 records were identified, of which 12 studies with 13 datasets (n = 39,809) were included after screening. The pooled prevalence of hypertension among people living with HIV in India was 19.37% (95% CI: 11.26-31.25%) under the random-effects model. However, substantial between-study heterogeneity was observed (I² = 93.9%, p < 0.0001), indicating considerable variability in the reported prevalence across studies. The risk-of-bias assessment showed variable methodological quality across studies, with the main concerns involving the sampling frame and sample size adequacy. The pooled prevalence across available studies was approximately 19%; however, substantial inter-study heterogeneity and limitations in study representativeness preclude interpretation as a nationally representative estimate. Further high-quality studies are needed to better characterize this burden.
No takes yet. Share an insight, caveat, or question.
Mondal et al. (2026) conducted a meta-analysis in People living with human immunodeficiency virus (PLHIV) (n=39,809). Human immunodeficiency virus (HIV) infection was evaluated on Pooled prevalence of hypertension (Prevalence 19.37%, 95% CI 11.26-31.25). Adults living with HIV in India had a pooled hypertension prevalence of 19.37%, with substantial between-study heterogeneity.
Synapse has enriched 10 related papers. Consider them for comparative context: